Jamaica, farewell At first glance, I didn’t know what to make of Aion Therapeutics (AION.C). There are a few moving parts, it’s a psychedelics/cannabis hybrid deal with a focus…
shroom stocks 2021
Doubling down on Cybin Back in January, Horizons’ (PYSK.NE) ETF held a relatively balanced portfolio of psychedelics companies. No company made up more than 10% of its holdings, with…
Forget weed crypto First off, most all of those crypto/cannabis hybrid deals were super cringe, and I never saw the point of combining the two, at least not at…
The NYSE Cybin (CYBN.N) just finished its first trading day on the New York Stock Exchange (NYSE) after announcing the upcoming uplisting last month. It was a less…
Mushroom enthusiasts Filament Health (FH.NE) is looking at mushroom compounds far beyond just psilocybin as the company is run by actual mushroom enthusiasts with access to a lot of…
It’s easy to see the word ‘ketamine’ on a press release and assume a company is a full-on psychedelics outfit. But it’s important to understand that even companies who…
SEO I’ve stayed pretty positive with regard to the psychedelics space so far, and while the company I am going to be talking about here isn’t a psychedelics company…
Everyone who went near a cannabis stock has probably seen or heard of Bruce Linton. He was a charismatic guy who rarely wore more than a t-shirt and jeans….
“Suicide Opportunity” I can’t remember what company it was, maybe MindMed, but one of their early pitch decks had a page titled ‘Suicide Opportunity’. Yesterday I wrote an…
Suicide is often impulsive Seelos (SEEL.Q) are looking to create a faster way for suicidal people to get help. Current treatments like SSRI’s and anti-depressants help some, but…